The development and use of large and dynamic health data repositories designed to support research pose challenges to traditional informed consent models. We used semi-structured interviewing (n=44) to elicit diverse research stakeholders' views of a model of consent appropriate to participation in initiatives that entail collection, long-term storage, and undetermined future research use of multiple types of health data. We demonstrate that, when considering health data repositories, research stakeholders replace a concept of consent as informed with one in which consent is engaged. In engaged consent, a participant's ongoing relationship with a repository serves as a substitute or adjunct to information exchange at enrollment. We detail research stakeholders' views of the risks of engaged consent and suggest questions for further study about engagement and consent procedures in initiatives that aim to store data for future unspecified research purposes.
Get full access to this article
View all access options for this article.
References
1.
A.L.McGuire and L.M.Beskow, “Informed Consent in Genomics and Genetic Research,”Annual Review of Genomics and Human Genetics11, no. 1 (2010): 361-381, at 362.
2.
45 CFR 46.116 (2018).
3.
R.R.Faden, T.L.Beauchamp, and N.E.Kass. “Informed Consent, Comparative Effectiveness, and Learning Health Care,”New England Journal of Medicine370, no. 8 (2014): 766-768.
4.
P.L.Sankar and L.S.Parker, “The Precision Medicine Initiative's All of Us Research Program: An Agenda for Research on its Ethical, Legal, and Social Issues,”Genetics in Medicine19, no. 7 (2017): 743.
5.
See McGuire and Beskow, supra note 1, at 362.
6.
D.Khodyakov, A.Mendoza-Graf, S.Berry, C.Nebecker, and E.Bromley. “Return of Value in the New Era of Biomedical Research — One Size Will Not Fit All,”AJOB Empirical Bioethics10, no. 4 (2019): 265-275.
7.
L.M.Beskow and K. P.Weinfurt, “Exploring Understanding of ‘Understanding’: The Paradigm Case of Biobank Consent Comprehension,”The American Journal of Bioethics19, no. 5 (2019): 6-18.
8.
S.Wieten, J.Blythe, and D.Magnus, “Informed Consent: A Matter of Aspiration Since 1966 (At Least),”The American Journal of Bioethics19, no. 5 (2019): 3-5.
9.
E.W.Clayton, “The Unbearable Requirement of Informed Consent,”The American Journal of Bioethics19, no. 5 (2019): 19-20, at 19.
10.
A. M.Capron, “Where Did Informed Consent for Research Come From?”The Journal of Law, Medicine & Ethics46, no. 1 (2018): 12-29.
11.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report, (Department of Health, Education, and Welfare: 1979).
12.
J.Flory and E.Emanuel, “Interventions to Improve Research Participants' Understanding in Informed Consent for Research: A Systematic Review,”JAMA292, no. 13 (2004): 1593-1601.
13.
B.W.Palmer, E.L.Cassidy, L.B.Dunn, A.P.Spira, and J.I.Sheikh, “Effective Use of Consent Forms and Interactive Questions in the Consent Process,”IRB: Ethics & Human Research30, no. 2 (2008): 8-12.
14.
Y.G.De Souza and J.S.Greenspan, “Biobanking Past, Present and Future: Responsibilities and Benefits,”AIDS27, no. 3 (2013): 303-312.
15.
D. J.Kaufman, R.Baker, L. C.Milner, S.Devaney, and K. L.Hudson, “A Survey of U.S Adults' Opinions about Conduct of a Nationwide Precision Medicine Initiative Cohort Study of Genes and Environment,”PloS One11, no. 8 (2016): e0160461.
16.
L.M.Beskow, C.B.Dombeck, C.P.Thompson, J.K.Watson-Ormond, and K.P.Weinfurt, “Informed Consent for Biobanking: Consensus-Based Guidelines for Adequate Comprehension,”Genetics in Medicine17, no. 3 (2015): 226.
17.
45 CFR §§ 46, subparts A-D (2017).
18.
C.Grady, L.Eckstein, and B.Berkman,et al., “Broad Consent for Research with Biological Samples: Workshop Conclusions, The American Journal of Bioethics15, no. 9 (2015): 34-42, at 35.
19.
Guidance on Broad Consent Under the Revised Common Rule, Attachment C - Recommendations for Broad Consent Guidance, Secretary's Advisory Committee on Human Research Protections, Department of Health and Human Services, July 26, 2017, np.
20.
Guidance on Broad Consent Under the Revised Common Rule, Attachment D - Recommendations for a Broad Consent Template, Secretary's Advisory Committee on Human Research Protections, Department of Health and Human Services, July 26, 2017, np.
21.
S.B.Garrett, D.Dohan, and B.A.Koenig, “Linking Broad Consent to Biobank Governance: Support From a Deliberative Public Engagement in California,”The American Journal of Bioethics15, no. 9 (2015): 56-57.
22.
E.M.Bunnik, A.C.J.W.Janssens, and M.H.N.Schermer, “A Tiered-Layered-Staged Model for Informed Consent in Personal Genome Testing,”European Journal of Human Genetics21, no. 6 (2013): 596-601.
23.
J.Lentz, M.Kennett, J.Perlmutter, and A.Forrest, “Paving the Way to a More Effective Informed Consent Process: Recommendations from the Clinical Trials Transformation Initiative,”Contemporary Clinical Trials49 (2016): 65-69.
24.
R.Wee, M.Henaghan, and I.Winship, “Ethics: Dynamic Consent in the Digital Age of Biology: Online Initiatives and Regulatory Considerations,”Journal of Primary Health Care5, no. 4 (2013): 341-347.
25.
See McGuire and Beskow, supra note 1.
26.
D.Wendler, Broad versus Blanket Consent for Research with Human Biological Samples,”Hastings Center Report43, no. 5 (2013): 3-4.
27.
T.Caulfield, “Biobanks and Blanket Consent: The Proper Place of the Public Good and Public Perception Rationales,”King's Law Journal18, no. 2 (2007): 209-226.
28.
H.T.Greely, “The Uneasy Ethical and Legal Underpinnings of Large-Scale Genomic Biobanks,”Annual Review of Genomics and Human Genetics8 (2007): 343-364.
29.
See supra note 19, np.
30.
K.E.Ormond, A.L.Cirino, I.B.Helenowski, R.L.Chisholm, and W.A.Wolf, “Assessing the Understanding of Biobank Participants,”American Journal of Medical Genetics149A (2009): 188–198.
31.
A.Mandava, C.Pace, B.Campbell, E.Emanuel, and C.Grady, “The Quality of Informed Consent: Mapping the Landscape, A Review of Empirical Data from Developing and Developed Countries,”Journal of Medical Ethics38, no. 6 (2012): 356–365.
32.
N.W.Dickert, N.Eyal, and S.F.Goldkind,et al, “Reframing Consent for Clinical Research: A Function-Based Approach,”The American Journal of Bioethics17, no. 12 (2017): 3-11, at 4.
33.
D.Brudney, “Choosing for Another: Beyond Autonomy and Best Interests,”Hastings Center Report39, no. 2 (2009): 31-37.
34.
See Faden et al., supra note 3.
35.
See Beskow and Weinfurt, supra note 7.
36.
See Beskow and Weinfurt, supra note 7, at 16.
37.
B.Solberg and L.Ursin, “Being Polite: Why Biobank Consent Comprehension Is Neither a Requirement nor an Aspiration,”The American Journal of Bioethics19, no. 5 (2019): 31-33.
38.
S. SolomonCargill, “Rejecting ‘Understanding’: An Ethical Proposal Whose Time Has Come,”The American Journal of Bioethics19, no. 5 (2019): 41-42, at 41.
39.
E.Parens, “Drifting Away from Informed Consent in the Era of Personalized Medicine,”Hastings Center Report45, no. 4 (2015): 16-20.
40.
K.D.Lakes, E.Vaughan, M.Jones, W.Burke, D.Baker, and J.M.Swanson, “Diverse Perceptions of the Informed Consent Process: Implications for the Recruitment and Participation of Diverse Communities in the National Children's Study,”American Journal of Community Psychology49, no. 1-2 (2012): 215-232.
41.
See Parens, supra note 39, at 17.
42.
See Parens, supra note 39, at 17.
43.
See Parens, supra note 39, at 19.
44.
P.S.Appelbaum, “Ignorance Isn't Bliss: Retaining a Meaningful Comprehension Requirement for Consent to Research,”The American Journal of Bioethics19, no. 5 (2019): 22-24.
45.
M.Zawati and B.M.Knoppers, “Reciprocity and the Quest for Meaningful Disclosure,”The American Journal of Bioethics19, no. 5 (2019): 36-38.
46.
N.W.Dickert, “The Value of Consent for Clinical Research Does Not Always Hinge on Understanding,”The American Journal of Bioethics19, no. 5 (2019): 20-22, at 21.
47.
G.E.Henderson, T.P.Edwards, and R.J.Cadigan,et al., “Stew-ardship Practices of U.S. Biobanks,”Science Translational Medicine5 (2013): np.
48.
G.T.Laurie, E.S.Dove, and A.Ganguli-Mitra,et al., “Charting Regulatory Stewardship in Health Research: Making the Invisible Visible,”Cambridge Quarterly of Healthcare Ethics27, no. 2 (2018): np.
49.
G.Moreno-John, C.Fleming, and M.E.Ford,et al., “Mentoring in Community-Based Participatory Research: The RCMAR Experience,”Ethnicity & Disease17, no. 1 (2007): 33-43.
50.
M.M.Burgess and K.C.O'Doherty, “Moving From Understanding of Consent Conditions to Heuristics of Trust,”The American Journal of Bioethics19, no. 5 (2019): 24-26.
